Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
21.6%
% of GDOC's 39 holdings also in FBT
26.7%
% of FBT's 31 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GDOC |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
BIOMARIN PHARMACEUTICAL INC | 3.3% | 3.4% | 3.3% |
 |
ARGENX SE ADR | 2.3% | 3.4% | 2.3% |
|
NEUROCRINE BIOSCIENCES INC | 2.1% | 3.7% | 2.1% |
|
ALNYLAM PHARMACEUTICALS INC | 1.7% | 3.4% | 1.7% |
 |
METTLER-TOLEDO INTERNATIONAL | 1.4% | 3.3% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to FBT
|
ELI LILLY & CO | 9.7% |
|
BOSTON SCIENTIFIC CORP | 8.3% |
|
ABBVIE INC | 6.4% |
|
INTUITIVE SURGICAL INC | 5.8% |
|
ABBOTT LABORATORIES | 5.2% |
|
UNITEDHEALTH GROUP INC | 5.2% |
|
INSULET CORP | 4.4% |
 |
ASTRAZENECA PLC | 4.2% |
|
MERCK & CO. INC. | 4.0% |
|
COOPER COS INC/THE | 3.8% |
GDOC Underweight Relative to FBT
|
SAREPTA THERAPEUTICS INC | -3.8% |
 |
ALKERMES PLC | -3.6% |
|
REPLIGEN CORP | -3.6% |
 |
GENMAB A/S SPONSORED ADR | -3.5% |
|
EXELIXIS INC | -3.5% |
|
BEIGENE LTD. SPONSORED ADR | -3.4% |
|
INCYTE CORP | -3.4% |
|
REGENERON PHARMACEUTICALS | -3.4% |
|
WATERS CORP | -3.3% |
|
BIOGEN IDEC INC | -3.3% |